As shown in Figure 8, 100% and 69% of ACC tumor samples expressed transcripts encoding GABBR1 and GABBR2, with upregulation in 8% and 15% of patients, respectively. This evidence concerns the gene GABBR2 and adrenal cortex carcinoma.